1. Home
  2. TTMI vs AKRO Comparison

TTMI vs AKRO Comparison

Compare TTMI & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTMI
  • AKRO
  • Stock Information
  • Founded
  • TTMI 1978
  • AKRO 2017
  • Country
  • TTMI United States
  • AKRO United States
  • Employees
  • TTMI N/A
  • AKRO N/A
  • Industry
  • TTMI Electrical Products
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TTMI Technology
  • AKRO Health Care
  • Exchange
  • TTMI Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • TTMI 1.9B
  • AKRO 2.1B
  • IPO Year
  • TTMI 2000
  • AKRO 2019
  • Fundamental
  • Price
  • TTMI $22.09
  • AKRO $32.33
  • Analyst Decision
  • TTMI Strong Buy
  • AKRO Strong Buy
  • Analyst Count
  • TTMI 4
  • AKRO 7
  • Target Price
  • TTMI $25.31
  • AKRO $43.20
  • AVG Volume (30 Days)
  • TTMI 703.2K
  • AKRO 505.3K
  • Earning Date
  • TTMI 10-30-2024
  • AKRO 11-11-2024
  • Dividend Yield
  • TTMI N/A
  • AKRO N/A
  • EPS Growth
  • TTMI N/A
  • AKRO N/A
  • EPS
  • TTMI 0.66
  • AKRO N/A
  • Revenue
  • TTMI $2,360,827,000.00
  • AKRO N/A
  • Revenue This Year
  • TTMI $9.43
  • AKRO N/A
  • Revenue Next Year
  • TTMI $5.32
  • AKRO N/A
  • P/E Ratio
  • TTMI $33.42
  • AKRO N/A
  • Revenue Growth
  • TTMI 3.51
  • AKRO N/A
  • 52 Week Low
  • TTMI $13.43
  • AKRO $13.39
  • 52 Week High
  • TTMI $23.61
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • TTMI 70.46
  • AKRO 64.31
  • Support Level
  • TTMI $19.40
  • AKRO $30.13
  • Resistance Level
  • TTMI $23.61
  • AKRO $32.70
  • Average True Range (ATR)
  • TTMI 0.74
  • AKRO 1.42
  • MACD
  • TTMI 0.27
  • AKRO 0.11
  • Stochastic Oscillator
  • TTMI 70.83
  • AKRO 86.40

About TTMI TTM Technologies Inc.

TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. The company organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: